PortfoliosLab logoPortfoliosLab logo
LSDIX vs. NEFRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LSDIX vs. NEFRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loomis Sayles Intermediate Duration Bond Fund (LSDIX) and Loomis Sayles Core Plus Bond Fund (NEFRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LSDIX achieves a 0.03% return, which is significantly lower than NEFRX's 0.31% return. Both investments have delivered pretty close results over the past 10 years, with LSDIX having a 2.23% annualized return and NEFRX not far behind at 2.17%.


LSDIX

1D
0.00%
1M
0.22%
YTD
0.03%
6M
0.17%
1Y
2.89%
3Y*
4.45%
5Y*
1.12%
10Y*
2.23%

NEFRX

1D
0.09%
1M
0.45%
YTD
0.31%
6M
0.08%
1Y
5.38%
3Y*
3.62%
5Y*
0.04%
10Y*
2.17%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LSDIX vs. NEFRX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LSDIX
Loomis Sayles Intermediate Duration Bond Fund
0.03%5.73%3.88%5.75%-8.55%-1.38%7.74%7.64%0.52%2.66%
NEFRX
Loomis Sayles Core Plus Bond Fund
0.31%7.24%0.60%5.91%-12.94%-1.68%10.29%8.76%-0.86%4.92%

Correlation

The correlation between LSDIX and NEFRX is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.86

Correlation (3Y)
Calculated over the trailing 3-year period

0.88

Correlation (5Y)
Calculated over the trailing 5-year period

0.89

Correlation (10Y)
Calculated over the trailing 10-year period

0.85

Correlation (All Time)
Calculated using the full available price history since Jan 29, 1998

0.83

The correlation between LSDIX and NEFRX has been stable across timeframes, ranging from 0.83 to 0.89 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LSDIX vs. NEFRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LSDIX
LSDIX Risk / Return Rank: 2121
Overall Rank
LSDIX Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
LSDIX Sortino Ratio Rank: 2121
Sortino Ratio Rank
LSDIX Omega Ratio Rank: 2222
Omega Ratio Rank
LSDIX Calmar Ratio Rank: 2323
Calmar Ratio Rank
LSDIX Martin Ratio Rank: 1919
Martin Ratio Rank

NEFRX
NEFRX Risk / Return Rank: 3131
Overall Rank
NEFRX Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NEFRX Sortino Ratio Rank: 3333
Sortino Ratio Rank
NEFRX Omega Ratio Rank: 2929
Omega Ratio Rank
NEFRX Calmar Ratio Rank: 3535
Calmar Ratio Rank
NEFRX Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LSDIX vs. NEFRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Intermediate Duration Bond Fund (LSDIX) and Loomis Sayles Core Plus Bond Fund (NEFRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LSDIXNEFRXDifference
Sharpe ratioReturn per unit of total volatility

-0.24

Sortino ratioReturn per unit of downside risk

-0.45

Omega ratioGain probability vs. loss probability

1.25

1.28

-0.03

Calmar ratioReturn relative to maximum drawdown

1.78

2.22

-0.44

Martin ratioReturn relative to average drawdown

5.11

6.44

-1.32

LSDIX vs. NEFRX - Sharpe Ratio Comparison

The current LSDIX Sharpe Ratio is 1.31, which is comparable to the NEFRX Sharpe Ratio of 1.55. The chart below compares the historical Sharpe Ratios of LSDIX and NEFRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LSDIXNEFRXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.31

1.55

-0.24

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.29

0.01

+0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.69

0.44

+0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

1.15

0.74

+0.41

Drawdowns

LSDIX vs. NEFRX - Drawdown Comparison

The maximum LSDIX drawdown since its inception was -12.92%, smaller than the maximum NEFRX drawdown of -25.45%. Use the drawdown chart below to compare losses from any high point for LSDIX and NEFRX.


Loading charts...

Drawdown Indicators


LSDIXNEFRXDifference

Max Drawdown

Largest peak-to-trough decline

-12.92%

-25.45%

+12.53%

Max Drawdown (1Y)

Largest decline over 1 year

-1.96%

-2.92%

+0.96%

Max Drawdown (3Y)

Largest decline over 3 years

-2.36%

-7.95%

+5.59%

Max Drawdown (5Y)

Largest decline over 5 years

-12.92%

-18.55%

+5.63%

Max Drawdown (10Y)

Largest decline over 10 years

-12.92%

-18.76%

+5.84%

Current Drawdown

Current decline from peak

-0.93%

-1.89%

+0.96%

Average Drawdown

Average peak-to-trough decline

-1.46%

-3.97%

+2.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.70%

1.17%

-0.47%

Volatility

LSDIX vs. NEFRX - Volatility Comparison

The current volatility for Loomis Sayles Intermediate Duration Bond Fund (LSDIX) is 0.75%, while Loomis Sayles Core Plus Bond Fund (NEFRX) has a volatility of 1.36%. This indicates that LSDIX experiences smaller price fluctuations and is considered to be less risky than NEFRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LSDIXNEFRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.75%

1.36%

-0.61%

Volatility (6M)

Calculated over the trailing 6-month period

1.83%

2.73%

-0.90%

Volatility (1Y)

Calculated over the trailing 1-year period

2.66%

4.19%

-1.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

3.95%

6.23%

-2.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

3.28%

5.04%

-1.76%

LSDIX vs. NEFRX - Expense Ratio Comparison

LSDIX has a 0.40% expense ratio, which is lower than NEFRX's 0.71% expense ratio.


Dividends

LSDIX vs. NEFRX - Dividend Comparison

LSDIX's dividend yield for the trailing twelve months is around 2.98%, less than NEFRX's 3.61% yield.


PositionTTM20252024202320222021202020192018201720162015
LSDIX
Loomis Sayles Intermediate Duration Bond Fund
2.98%3.35%4.24%3.72%2.38%1.75%4.56%3.13%2.69%2.24%2.94%2.75%
NEFRX
Loomis Sayles Core Plus Bond Fund
3.61%3.97%3.90%3.58%3.10%2.34%4.04%2.51%2.87%2.68%3.17%2.58%

Frequently Asked Questions


LSDIX and NEFRX have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NEFRX has higher volatility (1.36%) compared to LSDIX (0.75%). In terms of maximum drawdown, LSDIX dropped -12.92% vs NEFRX's -25.45%.

NEFRX currently has the higher Sharpe Ratio (1.55 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LSDIX and NEFRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer